After Market Movers and After Hours Trading Activity Stocks - Stocks Telegraph (2024)

Momentus Inc.13 days ago

MOMENTUS ANNOUNCES CLOSING OF $4.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

News

san jose, calif.--(business wire)--momentus inc. (nasdaq: mnts) (“momentus” or the “company”), a u.s. commercial space company that offers satellite buses, transportation, and other in-space infrastructure services, today announced that it has closed its previously announced registered direct offering priced at-the-market under nasdaq rules with a single institutional investor for the purchase and sale of 4,624,280 shares of common stock (or common stock equivalents in lieu thereof) at a purcha.

Aquestive Therapeutics, Inc.19 hours ago

AQUESTIVE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

News

warren, n.j., march 19, 2024 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. in addition, aquestive expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering. all of the securities in the public offering are being offered by aquestive. the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

AERWINS Technologies Inc.5 months ago

AERWINS PLANS TO OBTAIN XTURISMO FAA APPROVAL ESTABLISHED US SUBSIDIARY

News

tokyo, japan--(newsfile corp. - october 9, 2023) - aerwins technologies inc. (nasdaq: awin) ("aerwins" or the "company") announced today its board of directors has approved the establishment of a united states subsidiary in los angeles, california to pursue the redesign of its xturismo ltd edition prototype 1 hoverbike (the "xturismo"). these plans are intended to position the xturismo more favorably for wider markets, including the united states and europe and to seek certification of the xturismo by the u.s. federal aviation administration (the "faa").

Denali Capital Acquisition Corp.9 days ago

DENALI CAPITAL ACQUISITION CORP. ANNOUNCES EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION

News

new york , march 11, 2024 /prnewswire/ --denali capital acquisition corp. (nasdaq: deca) (the "company") announced today that an aggregate of $50,000 has been deposited into the company's trust account to further extend the period of time the company has to consummate its business combination by an additional month from march11, 2024 to april11, 2024 in accordance with the amended terms of the company's amended and restated memorandum and articles of association. about the company denali capital acquisition corp. is a blank check company incorporated as a cayman islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

Envoy Medical, Inc.3 days ago

COCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, ENCOURAGES ENVOY MEDICAL, INC. INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - COCH

News

new york , march 17, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of envoy medical, inc. (nasdaq: coch) resulting from allegations that envoy may have issued materially misleading business information to the investing public. so what:if you purchased envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Mitek Systems, Inc.19 hours ago

MITEK REPORTS RECORD REVENUE AND EARNINGS FOR FISCAL 2023

News

san diego--(business wire)--mitek systems, inc. (nasdaq: mitk, www.miteksystems.com, “mitek” or the “company”), a global leader in digital identity and fraud prevention, today reported financial results for its fourth quarter and full fiscal year ended september 30, 2023, and reiterated its previously provided guidance for its 2024 fiscal year ending september 30, 2024. fiscal 2023 full year financial highlights total revenue increased 19% to a record $172.6 million. gaap operating income incre.

Society Pass Incorporated2 months ago

SOCIETY PASS INC. (NASDAQ: SOPA) 1Q 2024 SHAREHOLDER UPDATE AND ANALYST RECOMMENDATIONS

News

new york, jan. 10, 2024 (globe newswire) -- society pass inc. (nasdaq: sopa) (“sopa” or the “company”), southeast asia's (sea) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, continues to capture the attention of financial analysts and investors, receive positive recommendations and achieve significant milestones. sopa has accomplished annual triple digit revenue growth over the past four years through its innovative business model by acquiring high growth companies such as: thoughtful media group , athailand-based, a social commerce-focused, premium digital video multi-platform network; nusatrip , a leadingindonesia-basedonline travel agency; vleisure , vietnam's leading provider of hotel management and payment solutions; gorilla global , a singapore-based, mobile network operator;and leflair , vietnam's leading lifestyle e-commerce platform.

Abeona Therapeutics Inc.2 days ago

ABEONA THERAPEUTICS REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND ANNOUNCES COMPLETION OF FDA INSPECTIONS

News

- fda completed pre-license inspection of abeona's cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal phase 3 viital™ study - - fda completed pre-license inspection of abeona's cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal phase 3 viital™ study -

Primech Holdings Ltd.5 months ago

PRIMECH HOLDINGS LTD. ANNOUNCES PRICING OF US12.2 MILLION INITIAL PUBLIC OFFERING

News

singapore, oct. 09, 2023 (globe newswire) -- primech holdings ltd.. (the “company” or “primech”), an established technology-driven facilities services provider in the public and private sectors operating mainly in singapore, today announced the pricing of its initial public offering (the “offering”) of 3,050,000 ordinary shares at a public offering price of us$4.00 per ordinary share. the ordinary shares have been approved for listing on the nasdaq capital market and are expected to commence trading on october 10, 2023 under the ticker symbol “pmec”.

Bluejay Diagnostics, Inc.3 months ago

BLUEJAY DIAGNOSTICS ANNOUNCES CLOSING OF $3.5 MILLION PUBLIC OFFERING

News

acton, mass., jan. 02, 2024 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, today announced the closing of its previously announced public offering of 2,692,308 shares of the company's common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. the warrants have an exercise price of $1.30 per share and are immediately exercisable upon issuance for a period of five years following the date of issuance.

Jiuzi Holdings, Inc.4 months ago

JIUZI HOLDINGS RECEIVED NASDAQ NOTIFICATION LETTER REGARDING BID PRICE DEFICIENCY

News

hangzhou, china, nov. 17, 2023 (globe newswire) -- jiuzi holdings inc. (nasdaq: jzxn; the "company" or “jzxn”), an emerging new energy vehicle (nev) dealership group operating under the brand name "jiuzi" in china, announced today that on november 8, 2023, the company received a notification letter from the nasdaq listing qualifications staff of the nasdaq stock market llc (“nasdaq”) notifying the company that the minimum bid price per share for its class a ordinary shares has been below $1.00 for a period of 30 consecutive business days and the company therefore no longer meets the minimum bid price requirements set forth in nasdaq listing rule 5550(a)(2).

ImmunoPrecise Antibodies Ltd.6 days ago

IPA REPORTS FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS FOR THIRD QUARTER FISCAL YEAR 2024*

News

victoria, british columbia--(business wire)---- $ipa #ai--ipa (immunoprecise antibodies ltd.) (the “company” or “ipa”) (nasdaq: ipa), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its third quarter of the 2024 fiscal year (“fy24”), which ended january 31, 2024. “immunoprecise antibodies proudly reports a fourth consecutive quarter of record revenue, demonstrating our capability to fulfill the rising needs of both new and existing clien.

Hanryu Holdings, Inc.4 months ago

HANRYU HOLDINGS REPORTS THIRD QUARTER AND FIRST NINE MONTH 2023 FINANCIAL RESULTS

News

seoul, republic of south korea / accesswire / november 20, 2023 / hanryu holdings, inc. (nasdaq:hryu) (the "company" or "hanryu"), a media-tech company and creator of fantoo, an all-in-one social media experience connecting k-culture fans globally, today reported its financial results for the third quarter and first nine months ended september 30, 2023. all amounts are expressed in u.s. dollars and are prepared under u.s. generally accepted accounting principles (gaap), unless indicated otherwise.

Crinetics Pharmaceuticals, Inc.1 day ago

CRINETICS' ONCE-DAILY ORAL PALTUSOTINE ACHIEVED THE PRIMARY AND ALL SECONDARY ENDPOINTS IN THE PHASE 3 PATHFNDR-2 STUDY IN ACROMEGALY PATIENTS

News

56% of participants on paltusotine achieved igf-1 ≤1.0 xuln vs. 5% on placebo (p

SIMPPLE LTD.6 months ago

SIMPPLE LTD. ANNOUNCES CLOSING OF US$8.4 MILLION INITIAL PUBLIC OFFERING

News

singapore, sept. 15, 2023 (globe newswire) -- simpple ltd. (nasdaq: sppl) (the “company” or “simpple”), an advanced technology solution provider in the emerging property-technology (“proptech”) space, today announced the closing of its initial public offering (the “offering”) of 1,602,000 ordinary shares at a public offering price of us$5.25 per ordinary share. the ordinary shares began trading on september 13, 2023 under the ticker symbol “sppl”.

Wetouch Technology Inc.2 days ago

WETOUCH ANNOUNCES STRATEGIC COLLABORATION WITH IDEC CORPORATION, ELEVATING PRESENCE IN JAPANESE TOUCH DISPLAY MARKET

News

chengdu, china , march 18, 2024 /prnewswire/ --wetouch technology inc.(nasdaq: weth), a pioneering force in the global touch display industry, is proud to announce its latest milestone in establishing a robust international footprint. through relentless dedication to innovation and customer satisfaction, wetouch has solidified its position as a trusted provider of high-quality touch display solutions worldwide.

Safe and Green Development Corporation9 days ago

SAFE AND GREEN DEVELOPMENT CORP LAUNCHES XENE AI EXCLUSIVE WAITING LIST

News

miami, fla, march 11, 2024 (globe newswire) -- safe and green development corporation (nasdaq: sgd) (“sg devco” or the “company”) is pleased to announce an update to the previously announced launch of the xene home platform.

Tango Therapeutics, Inc.2 days ago

TANGO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS

News

boston--(business wire)--tango therapeutics, inc. (nasdaq: tngx), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the fourth quarter and full year ended december 31, 2023, and provided business highlights. “in 2023, we made meaningful progress developing precision oncology treatments and now have four ongoing phase 1/2 clinical trials. these treatments have the potential to reach.

Glaukos Corporation28 days ago

GLAUKOS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

aliso viejo, calif.--(business wire)--glaukos corporation (nyse: gkos), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the fourth quarter and full year ended december 31, 2023. key highlights include: record net sales of $82.4 million in q4 2023 increased 16% year-over-year on a reported basis and 15% year-over-year on a constant currency basis. gl.